The FDA has approved new, updated COVID-19 vaccines, which have been formulated to more closely target current variants and provide better protection against severe consequences.
Fall is just around the corner, which generally means an uptick in infectious respiratory diseases, including (yes, again) COVID. One particularly acute example of this
The more that has been learned about COVID-19, both during and after the pandemic, the more it was determined that the ventilation system of a
In last week’s article, we discussed indicators that we’re seeing a potential uptick in COVID cases this summer or in the fall. Since the pandemic,
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
A new COVID Omicron subvariant (XBB.1.16, known as “Arcturus”) has been making headlines recently for being highly contagious and causing conjunctivitis (pink eye). As discussed
While COVID appears to be on a downward trend across much of the globe, including the U.S., there continue to be hotspots and surges, particularly
COVID continues to make news in the U.S. and around the world. With the XBB.1.5 variant now the dominant strain in the U.S., there is
It may be a new year, but influenza, RSV, and COVID cases are all continuing to have an impact as we move into 2023. Currently
Rates of respiratory diseases typically tend to increase this time of year, but this year’s increase is anything but typical. Not only are we seeing
